Channel:  NF Open Science Initiative

21 Articles

Inhibition of autophagy as a novel therapy for the treatment of neurofibromatosis type 1 tumors
Stevens, M., Wang, Y., Bouley, S. J., Mandigo, T. R., Sharma, A., Sengupta, S., Housden, A. E., Oltean, S., Perrimon, N., Walker, J. A., Housden, B. E.
10.1101/2021.12.20.473481 — Posted: 2023-08-26
Schwann cells modulate nociception in neurofibromatosis 1
Raut, N. G., Maile, L. A., Oswalt, L. M., Mitxelena, I., Adlakha, A., Sprague, K. L., Rupert, A. R., Bokros, L., Hofmann, M. C., Patritti-Cram, J., Rizvi, T. A., Queme, L. F., Choi, K., Ratner, N., Jankowski, M. P.
10.1101/2023.03.18.533004 — Posted: 2023-03-19
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors
Wang, J., Calizo, A., Zhang, L., Pino, J. C., Lyu, Y., Pollard, K., Zhang, X., Larsson, A. T., Conniff, E., Llosa, N., Wood, D. K., Largaespada, D. A., Moody, S. E., Gosline, S. J., Hirbe, A. C., Pratilas, C. A.
10.1101/2023.02.02.526674 — Posted: 2023-02-03
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma
MacKenzie, C. C., Vitte, J., Liu, C. H., Wright, E. A., Flynn, E. A., Stott, S. L., Giovannini, M., McClatchey, A. I.
10.1101/2020.12.31.424999 — Posted: 2023-01-23
Reciprocal inflammatory signaling in an ex-vivo explant model for neurofibromatosis type 1-related cutaneous neurofibromas
Grit, J., Turner, L., Essenburg, C., Dischinger, P., Shurlow, N., Pate, M., Graveel, C. R., Steensma, M. R.
10.1101/2022.10.06.510849 — Posted: 2022-10-06
Antisense oligonucleotides targeting exon 11 are able to partially rescue the Neurofibromatosis Type 2 phenotype in vitro
Catasus, N., Rosas, I., Bonache, S., Negro, A., Torres-Martin, M., Plana, A., Salvador, H., Serra, E., Blanco, I., CASTELLANOS, E.
10.1101/2022.02.11.479859 — Posted: 2022-10-04
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology
Bhatia^, H., Larsson^, A. T., Calizo^, A., Pollard, K., Zhang, X., Conniff, E., Tibbitts, J. F., Osum, S. H., Williams, K. B., Crampton, A. L., Jubenville, T., Schefer, D., Yang, K., Lyu, Y., Bade, J., Pino, J. C., Gosline, S. J., Pratilas, C. A., Largaespada, D. A., Wood, D. K., Hirbe, A. C.
10.1101/2022.04.29.490078 — Posted: 2022-05-26
Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA
Cortes-Ciriano, I., Steele, C. D., Piculell, K. G., Al-Ibraheemi, A., Eulo, V., Bui, M. M., Chatzipli, A., Dickson, B. C., Borcherding, D. C., Feber, A., Galor, A., Hart, J., Jones, K. B., Jordan, J. T., Kim, R. H., Lindsay, D., Miller, C., Nishida, Y., Proszek, P., Serrano, J., Sundby, R. T., Szymanski, J. J., Ullrich, N. J., Viskochil, D., Wang, X., Snuderl, M., Park, P. J., Flanagan, A. M., Hirbe, A. C., Pillay, N., Miller, D. T.
10.1101/2022.05.03.490481 — Posted: 2022-05-11
A detailed landscape of genomic alterations in malignant peripheral nerve sheath tumor cell lines challenges the current MPNST diagnosis
Magallon-Lorenz, M., Terribas, E., Fernandez, M. A., Requena, G., Rosas, I., Mazuelas, H., Uriarte, I., Negro, A., Castellanos, E., Blanco, I., DeVries, G., Kawashima, H., Legius, E., Brems, H., Mautner, V., Kluwe, L., Ratner, N., Wallace, M. R., Fernandez-Rodriguez, J., Lazaro, C., Fletcher, J., Reuss, D., Carrio, M., Gel, B., Serra, E.
10.1101/2022.05.07.491026 — Posted: 2022-05-08
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
Banerjee, J., Friedman, J. M., Klesse, L. J., Yohay, K., Jordan, J. T., Plotkin, S., Allaway, R. J., Blakeley, J. O.
10.1101/2022.03.31.22273208 — Posted: 2022-04-01

RSS  Channel RSS